Interventional cardiology in a whole new light

Open menu

News & Events

OPSENS REPORTS 2017 RESULTS – CONSOLIDATED REVENUES UP 85% FOR FISCAL 2017

15 November 2017

  OPSENS REPORTS 2017 RESULTS – CONSOLIDATED REVENUES UP 85% FOR FISCAL 2017 Quebec City, Quebec, November 15, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the year ended August 31, 2017. Highlights Record consolidated revenues for fiscal year 2017 at $17.8 million; Revenues for Fractional Flow Reserve (“FFR”)…

Read more

OPSENS GETS TECHNOLOGICAL AWARD

24 October 2017

Quebec City, Quebec, October 24, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) is proud to announce that its wholly owned subsidiary Opsens Solutions has received the first prize in the category “Best Innovative Product – Physics Measurements” in the Technological Awards Ranking of the magazine Mesures. This honor was bestowed upon Opsens during…

Read more

VISIT OPSENS MEDICAL AT TCT 2017

25 September 2017

Learn more about OptoWire at booth #5014 at the Transcatheter Cardiovascular Therapeutics Conference (TCT) 2017, and attend the Opsens sponsored complimentary lunch educational symposium, “Beyond FFR: New Nonhyperemic Indices in the Cath Lab”. Educational Symposium Objectives:  Update on procedures involving challenging patient subsets Examine current evidence related to FFR and non-hyperemic indices Case review of FFR and non-hyperemic index…

Read more

OPSENS PRESENTS A SHORT FILM AT THE INTERNATIONAL MEDICAL FILM FESTIVAL

19 September 2017

OPSENS PRESENTS A SHORT FILM AT THE INTERNATIONAL MEDICAL FILM FESTIVAL Quebec City, Quebec, September 13, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) is proud to announce that it has been invited to present a short film as part of International Medical Film Festival – Quebec in Good Health. The film features the OptoWire, Opsens’…

Read more

Opsens – Q3 Results

29 June 2017

OPSENS REPORTS Q3 2017 RESULTS  ANOTHER RECORD QUARTER WITH REVENUES UP 130% TO $4.9 MILLION Quebec City, Quebec, June 29, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the third quarter ended May 31, 2017. Highlights Growth in sales of products to measure Fractional Flow Reserve (“FFR”) in Q3 2017 to…

Read more

VISIT OPSENS MEDICAL AT THE 13TH ANNUAL C3 CONFERENCE

9 June 2017

Learn more about OptoWire Deux at booth #211 at the 13th Annual Complex Cardiovascular Catheter Therapeutics (C3) Conference, and attend the Opsens sponsored complimentary breakfast educational symposium, “Applying Advanced Physiology Technology in the New PCI Era”. This program is geared toward the interventionalist seeking to better understand complex PCI in the modern era. Presentations will…

Read more

ROBIN VILLENEUVE APPOINTED AS CHIEF FINANCIAL OFFICER

7 June 2017

ROBIN VILLENEUVE APPOINTED AS CHIEF FINANCIAL OFFICER Quebec City, Quebec, June 7, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS)(OTCQX:OPSSF) today announces that to support its growth phase and positioning in the medical market, the Company recruited Robin Villeneuve as Chief Financial Officer. This appointment enters into force immediately. Mr. Villeneuve recently worked as…

Read more

OPSENS ANNOUNCES DEPARTURE OF CFO

5 May 2017

OPSENS ANNOUNCES DEPARTURE OF CFO Quebec City, Quebec, May 05, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) has today announced the departure of Mr. Thierry Dumas, Chief Financial Officer and Corporate Secretary. Mr. Dumas will leave the Company on May 12, 2017. Mr. Louis Laflamme, Opsens’ current President and Chief Executive Officer, will assume…

Read more

VISIT OPSENS MEDICAL AT THE SCAI 2017 SCIENTIFIC SESSIONS

25 April 2017

Learn more about OptoWire Deux at booth #615 at the SCAI 2017 Scientific Sessions, and attend the Opsens sponsored complimentary dinner educational symposium, “Applying Advanced Physiology Technology in the New PCI Era”. This program is geared toward the interventionalist seeking to better understand complex PCI in the modern era. Presentations will focus on the latest…

Read more

OPSENS REPORTS Q2 2017 RESULTS – QUARTERLY CONSOLIDATED REVENUES UP 75% TO $4.8 MILLION

19 April 2017

OPSENS REPORTS Q2 2017 RESULTS – QUARTERLY CONSOLIDATED REVENUES UP 75% TO $4.8 MILLION Quebec City, Quebec, April 19, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the second quarter ended February 28, 2017. Highlights Growth in sales of products to measure Fractional Flow Reserve (“FFR”) in Q2 2017 at…

Read more